Program areas at CFF
Cfft supported a national clinical research network of nearly 80 foundation-accredited care centers that collaborate to conduct clinical trials, allowing potential new cf therapies to move to larger, late-stage studies more quickly. Medical programs in 2017 consisted of costs to support scientific study and investigations. 465 grants were awarded in 2017.
Funding by Cystic Fibrosis Foundation Therapeutics (cfft) in state-of-the-art contracted research has accelerated progress toward developing new cf treatments and finding a cure for the disease. By funding cf drug discovery and development research conducted by biotechnology companies and providing matching awards to cf drug developers for cf research, and with a specialized cf clinical trials network, cfft has attracted significant industry involvement in the fight against cf. The cf pipeline had 30 therapies in development for cf in 2017. Cfft accomplishes its mission by funding life-saving research to discover and develop effective therapies for people with cf. Cfft has funded hundreds of millions of dollars of research costs to help discover/develop cf drugs and therapies. Through cffts efforts, the life expectancy of people with cf has doubled in the last 30 years, and research to find a cure is more promising than ever before.
Who funds Cystic Fibrosis Foundation Therapeutics (CFF)
Grants from foundations and other nonprofits
Personnel at CFF
| Name | Title | Compensation | Date of data |
|---|
| Marc S Ginsky | Chief Operating Officer and Director / President and Director / Executive Vice President and Chief Operating Officer / Executive Vice President , Chief Operating Officer and Secretary | $0 | 2021-12-31 |
| Irena Barisic | Treasurer | $0 | 2023-11-14 |
| Vera H Twigg | Treasurer and Director / Executive Vice President , Chief Financial Officer and Secretary / Executive Vice President and Chief Financial Officer | $0 | 2021-12-31 |
| Preston W. Campbell, Iii, M.D. | President and Chief Executive Officer | $304,574 | 2019-08-11 |
| C Richard Mattingly | Former Chief Operating Officer | $0 | 2016-12-31 |
| ...and 1 more key personnel |
Financials for CFF
| Revenues | FYE 12/2022 | FYE 12/2021 | % Change |
|---|
| Total grants, contributions, etc. | $0 | $0 | - |
| Program services | $0 | $0 | - |
| Membership dues | $0 | $0 | - |
| Investment income and dividends | $0 | $0 | - |
| Net gain from sale of non-inventory assets | $0 | $0 | - |
| Net income from gaming activities and fundraising events, combined | $0 | $0 | - |
| Net income from sales of inventory | $0 | $0 | - |
| Miscellaneous revenues | $0 | $0 | - |
| Total revenues | $0 | $0 | - |
Organizations like CFF
| Organization | Type | Location | Revenue |
|---|
| Huntington's Disease Youth Organization of America | 501(c)(3) | Livonia, MI | $220,565 |
| International FOP Association | 501(c)(3) | North Kansas City, MO | $3,050,181 |
| WFH Usa | 501(c)(3) | Albany, NY | $684,615,118 |
| Sickle Cell 101 | 501(c)(3) | San Jose, CA | $246,717 |
| The Bow Foundation | 501(c)(3) | Charlottesville, VA | $370,375 |
| The New York City Foundation For Cerebral Palsy | 501(c)(3) | New York, NY | $32,294,945 |
| World Craniofacial Foundation | 501(c)(3) | Dallas, TX | $2,253,984 |
| Universal Mission | 501(c)(3) | Florissant, MO | $22,500 |
| Pietros Fight | 501(c)(3) | Staten Island, NY | $88,021 |
| STXBP1 Foundation | 501(c)(3) | Holly Springs, NC | $1,830,890 |
Data update history
December 25, 2023
Posted financials
Added Form 990EZ for fiscal year 2022
December 25, 2023
Updated personnel
Identified 1 new personnel
Nonprofit Types
Grantmaking organizationsDisease research fundraisersDisease-focused nonprofitsCharities
Issues
HealthDiseases and disorders
Characteristics
Conducts researchPartially liquidatedOperates internationallyTax deductible donationsNo full-time employeesAccepts online donations
Free account sign-up
Want updates when CFF has new information, or want to find more organizations like Cystic Fibrosis Foundation Therapeutics (CFF)?
Create free Cause IQ account